Allergy and Immunology · Atlantis, FL
NPI
1760489553
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5507 S Congress Ave, Suite 140
Atlantis, FL, 33462
Phone (561) 965-6685
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
56,275 services
Medicare patients, 2024
538
Average age 75
Drug cost, 2024
$1.6M
3,124 prescriptions
Company payments, 2025
$260
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven J Louie was code J2357 (injection, omalizumab, 5 mg), 19,560 times for 42 patients. In total Steven J Louie billed 56,275 services in 38 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 19,560 | 42 | $29.85 | $584K |
| J2182 Injection, mepolizumab, 1 mg | Office | 11,001 | 11 | $23.81 | $262K |
| 95004 Test - Miscellaneous | Office | 5,171 | 84 | $3.01 | $16K |
| 95165 Treatment - Miscellaneous | Office | 3,610 | 107 | $11.24 | $41K |
| 95024 Test - Miscellaneous | Office | 1,739 | 68 | $6.29 | $11K |
| 95117 Treatment - Miscellaneous | Office | 1,651 | 101 | $8.63 | $14K |
| 95044 Test - Miscellaneous | Office | 1,024 | 16 | $4.06 | $4,156 |
| 96372 Injection Administration | Office | 1,011 | 72 | $10.76 | $11K |
| 99213 Office E&M - Established | Office | 878 | 414 | $65.78 | $58K |
| 95115 Treatment - Miscellaneous | Office | 820 | 44 | $7.50 | $6,146 |
| 99214 Office E&M - Established | Office | 355 | 194 | $94.70 | $34K |
| 94060 Pulmonary Function Testing | Office | 165 | 151 | $29.58 | $4,880 |
| 95012 Pulmonary | Office | 154 | 140 | $14.22 | $2,190 |
| 99204 Office E&M - New | Office | 135 | 135 | $122.58 | $17K |
| 36415 Venipuncture Blood Collection | Office | 110 | 86 | $8.62 | $948 |
By year: 2022 $1.2M for 56,063 services; 2023 $1.2M for 57,157 services; 2024 $1.2M for 56,275 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 110 | 86 | $8.62 | $948 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven J Louie prescribed most often to Medicare patients was Montelukast Sodium, with 499 prescriptions and refills. In total Steven J Louie wrote 3,124 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 499 | 1,246 | 153 | $4,763 |
| Levocetirizine Dihydrochloride Generic | 391 | 886 | 129 | $5,250 |
| Azelastine Hcl Generic | 255 | 411 | 98 | $6,234 |
| Fluticasone Propionate Generic | 200 | 353 | 82 | $3,059 |
| Ipratropium Bromide Generic | 167 | 288 | 69 | $5,608 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 117 | 123 | 71 | $2,821 |
| Symbicort Budesonide/Formoterol Fumarate | 110 | 169 | 33 | $35K |
| Xolair Omalizumab | 108 | 115 | 16 | $362K |
| Tezspire Tezepelumab-Ekko | 90 | 90 | Under 11 | $377K |
| Arnuity Ellipta Fluticasone Furoate | 88 | 106 | 21 | $25K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 73 | 102 | 22 | $65K |
| Breo Ellipta Fluticasone/Vilanterol | 71 | 101 | 16 | $37K |
| Prednisone Generic | 68 | 69 | 50 | $110 |
| Nucala Mepolizumab | 60 | 60 | Under 11 | $221K |
| Famotidine Generic | 53 | 110 | 16 | $608 |
Brand drugs: 1,039 claims; generic drugs: 2,085 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven J Louie $260 ($260 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $66.63.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.